Persbericht

23/09/2020 Fluxys - Resultaten eerste semester 2020 (23.9.2020)
23/09/2020 Bpost - Henri de Romrée verlaat de group eind 2020 om familiale redenen (23.9.2020)
22/09/2020 Greenyard - announces the decisions taken by the shareholders’ meeting (22.9.2020)
22/09/2020 UCB - Achieves Important Regulatory Milestone for Bimekizumab (22.9.2020)
21/09/2020 Ageas - kondigt de bijzondere algemene vergadering van aandeelhouders van ageas SA/NV aan (21.9.2020)
21/09/2020 Aedifica - Bouw van twee zorgresidenties in Nederland (21.9.2020)
21/09/2020 Materialise - Joins Forces with Ditto to Advance Digital Technologies in the Eyewear Industry (21.9.2020)
18/09/2020 Oxurion - Business Update - H1 2020 (17.9.2020)
18/09/2020 Engie - Board of Directors requests an improvement of the terms proposed by VEOLIA and is open to alternative offers (17.9.2020)
18/09/2020 Total - U.S. Department of Energy’s National Energy Technology Laboratory Announces Investment to Further Develop LH CO2MENT Colorado Project (17.9.2020)
18/09/2020 FSMA - WERKT HAAR LIJST VAN VERDACHTE WEBSITES BIJ
17/09/2020 Greenyard - returns to profitable growth and raises adjusted EBITDA guidance (17.9.2020)
16/09/2020 FSMA - waarschuwt het publiek voor de activiteiten van Akita Michinoku Company, een vennootschap die beleggingsdiensten verstrekt
15/09/2020 Kiadis - receives $9.5 million from the Advanced Regenerative Manufacturing Institute’s BioFabUSA Program to fund Kiadis K-NK cell COVID-19 therapy (15.9.2020)
15/09/2020 Aedifica - Bouw van een zorgresidentie in Nederland (14.9.2020)
14/09/2020 Euronext - STATEMENT REGARDING BORSA ITALIANA (14.9.2020)
14/09/2020 Kiadis - announces U.S. FDA approval for a COVID-19 clinical trial (14.9.2020)
14/09/2020 Biocartis - Large Prospective Lung Cancer Study To Be Presented (14.9.2020)
12/09/2020 Abo - Halfjaarcijfers 2020 (11.9.2020)
12/09/2020 Exmar - RESULTATEN EERSTE SEMESTER 2020 (11.9.2020)